Uniqure NV (NASDAQ:QURE)

19.10
Delayed Data
As of Jun 24
 -0.44 / -2.25%
Today’s Change
12.52
Today|||52-Week Range
38.80
-7.91%
Year-to-Date
uniQure (QURE) Up on Safety Data From Huntington's Disease Study
Jun 24 / Zacks.com - Paid Partner Content
Why uniQure's Stock Price Jumped Today
Jun 23 / MotleyFool.com - Paid Partner Content
uniQure (QURE) Moves 27% Higher: Will This Strength Last?
Jun 24 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close19.54
Today’s open19.71
Day’s range18.18 - 19.88
Volume67,609
Average volume (3 months)607,071
Market cap$659.1M
Data as of 4:01pm ET, 06/24/2022

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-145.55%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+1,296.82%
P/E ratio2.7
Price/Sales1.85
Price/Book1.10

Competitors

 Today’s
change
Today’s
% change
ALECAlector Inc+0.21+2.00%
MORFMorphic Holding Inc-0.48-2.04%
REPLReplimune Group Inc-0.09-0.48%
DCPHDeciphera Pharmaceut...-0.24-1.72%
Data as of 4:01pm ET, 06/24/2022

Financials

Next reporting dateAugust 3, 2022
EPS forecast (this quarter)-$1.00
Annual revenue (last year)$524.0M
Annual profit (last year)$329.6M
Net profit margin62.90%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Amsterdam, Noord-holland

Forecasts